CAPTURE your learning

Prescribers are instrumental in framing a medicine positively or negatively, setting patient expectations. Optimising these expectations during a short consult can enhance and sustain benefits. Conversely, highlighting negative information may lead to increased experience, and reporting, of adverse events, and to poor adherence.

Episode three of our Legendary Conversations podcast is out now! Listen to three experts as they discuss attitudes towards gout and how to better communicate with patients to improve gout outcomes. 

From 1 December 2021 rosuvastatin will be fully funded, subject to Special Authority criteria, for people at increased risk of cardiovascular complications due to high cholesterol. In addition, Māori and Pacific peoples with raised CVD risk may access rosuvastatin as first-line treatment, and a waiver process is available to patients already self-funding the medicine. 

Episode two of our Legendary Conversations podcast is out now! Listen to a scripted discussion that uses the ABC Health Literacy model when talking with a patient about starting a new medicine.

Looking for up-to-date information on gout? You can find it here!

We’ve linked resources from multiple providers into one place so it’s easy for you to find what you need.

Following on from presentations in February, this new resource covers discussions from webinars held in August 2021.

The content has been edited, and reviewed by Waikato DHB endocrinologist/diabetologist Dr Ryan Paul.

We recommend using Google Chrome when accessing this resource. You may experience technical difficulties on other internet browsers.